2021
DOI: 10.7759/cureus.15619
|View full text |Cite
|
Sign up to set email alerts
|

Management of Life-Threatening Bleeding in Patients With Mechanical Heart Valves

Abstract: Huda et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…In addition, due to the light construction of the lea ets, they violently decelerate at the valve closure, which causes haemolysis by squeezing the blood cells. Studies on mechanical heart valves, including aortic valves, aim to decrease the risk of thrombosis, which requires anticoagulation treatment with various medicaments [30]. Such research is commonly conducted by means of in silico modelling.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, due to the light construction of the lea ets, they violently decelerate at the valve closure, which causes haemolysis by squeezing the blood cells. Studies on mechanical heart valves, including aortic valves, aim to decrease the risk of thrombosis, which requires anticoagulation treatment with various medicaments [30]. Such research is commonly conducted by means of in silico modelling.…”
Section: Discussionmentioning
confidence: 99%
“…However, patients with CF‐LVAD have higher bleeding rates than do patients exposed to these agents in other settings (e.g. mechanical valves) 24 . Moreover, many CF‐LVAD patients with GIB present with subtherapeutic or normal international normalized ratio (INR) at the time of bleeding.…”
Section: Pathophysiologymentioning
confidence: 99%
“…Recognition of the severity of the bleeding and its origin is therefore essential. In a patient with a mechanical heart valve and a major haemorrhage, neutralisation of the anticoagulant should also be carried out while assessing the thrombotic risk associated with the delay before reintroduction of the anticoagulant [8]. Although activated charcoal is effective in reducing plasma concentrations of anticoagulants, its administration is not recommended in international guidelines in cases of major bleeding.…”
Section: Fatal Haemorrhagementioning
confidence: 99%
“…With treatment with acenocoumarol (Sintrom®, Merus Labs International, plasma elimination half-life 8-11 hours), warfarin (Coumandine®, Bristol-Myers Squibb, plasma elimination half-life 35-45 hours) or phenprocoumone (Marcoumar®, Meda, plasma elimination halflife 160 hours), the degree of anticoagulation is quantitatively reflected by prolongation of the PT (in seconds), most often reported as the prothrombin rate expressed as a percentage (PT%), or the INR, which increases when the PT% is lowered [8] . Many protocols rely on INR results to guide anticoagulation neutralisation.…”
Section: Vitamin K Antagonistsmentioning
confidence: 99%